Aixcrypto Holdings, INC. (AIXC) — 10-K Filings

All 10-K filings from Aixcrypto Holdings, INC.. Browse 3 Annual Report reports with AI-powered summaries and risk analysis.

10-K Filings (3)

AIxCrypto Pivots to AI, Blockchain Infrastructure After $40.7M Raise — Mar 30, 2026 Risk: high
AIxCrypto Holdings, Inc. (AIXC) underwent a significant strategic realignment in 2025, pivoting from therapeutics to a dual-pillar strategy focused on Real-Worl
Qualigen Therapeutics Navigates Pre-Revenue Stage with Capital Raises — Jun 30, 2025 Risk: high
Qualigen Therapeutics, Inc. reported no revenue for the fiscal year ended December 31, 2024, consistent with its pre-commercial stage as a pharmaceutical compan
Qualigen Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — Apr 8, 2024 Risk: medium
Qualigen Therapeutics, Inc. (AIXC) filed a Annual Report (10-K) with the SEC on April 8, 2024. Qualigen Therapeutics, Inc. filed its annual report on Form 10-K

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX